Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy

被引:60
作者
Asmuth, David M. [1 ,2 ]
Ma, Zhong-Min [3 ,4 ]
Albanese, Anthony [2 ]
Sandler, Netanya G. [5 ]
Devaraj, Sridevi [6 ,7 ]
Knight, Thomas H. [1 ]
Flynn, Neil M. [1 ]
Yotter, Tammy [1 ]
Garcia, Juan-Carlos [1 ]
Tsuchida, Emily [8 ]
Wu, Tsung-Teh [9 ]
Douek, Daniel C. [5 ]
Miller, Christopher J. [2 ,3 ]
机构
[1] Univ Calif Davis, Davis Med Sch, Sacramento, CA 95817 USA
[2] Vet Adm Northern Calif Healthcare Syst, Sacramento, CA USA
[3] Univ Calif Davis, Davis, CA 95817 USA
[4] Ctr Comparat Med, Davis, CA USA
[5] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] Texas Childrens Hosp, Houston, TX 77030 USA
[8] CARES Clin, Sacramento, CA USA
[9] Mayo Clin, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
bovine immunoglobulin; d-xylose absorption; gastrointestinal associated lymphoid tissue; gut permeability; HIV enteropathy; immune reconstitution; immunohistochemistry; intestinal fatty acid binding protein; monocyte chemotaxis protein-1; LYMPHATIC TISSUE FIBROSIS; T-CELL DEPLETION; INTESTINAL BARRIER FUNCTION; DIETARY PLASMA-PROTEINS; DRIED PORCINE PLASMA; LYMPHOID-TISSUE; COLLAGEN DEPOSITION; BACTERIAL TRANSLOCATION; GASTROINTESTINAL-TRACT; ANIMAL PLASMA;
D O I
10.1097/QAD.0b013e328362e54c
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives:To examine the impact of serum-derived bovine immunoglobulin, an oral medical food known to neutralize bacterial antigen and reduce intestinal inflammation, on restoration of mucosal immunity and gastrointestinal function in individuals with HIV enteropathy. Design:Open-label trial with intensive 8-week phase of bovine serum immunoglobulin (SBI) 2.5g twice daily with a 4-week washout period and an optional 9-month extension study. Methods:HIV enteropathy was defined as chronic gastrointestinal symptoms including frequent loose or watery stools despite no identifiable, reversible cause. Upper endoscopy for tissue immunofluorescent antibody assay and disaccharide gut permeability/absorption studies were performed before and after 8 weeks of SBI to test mucosal immunity and gastrointestinal function. Blood was collected for markers of microbial translocation, inflammation, and collagen kinetics. A validated gastrointestinal questionnaire assessed changes in symptoms. Results:All eight participants experienced profound improvement in symptoms with reduced bowel movements/day (P=0.008) and improvements in stool consistency (P=0.008). Gut permeability was normal before and after the intervention, but d-xylose absorption increased in seven of eight participants. Mucosal CD4(+) lymphocyte densities increased by a median of 139.5cells/mm(2) from 213 to 322cells/mm(2) (P=0.016). Intestinal-fatty acid binding protein (I-FABP), a marker of enterocyte damage, initially rose in seven of eight participants after 8 weeks (P=0.039), and then fell below baseline in four of five who continued receiving SBI (P=0.12). Baseline serum I-FABP levels were negatively correlated with subsequent rise in mucosal CD4(+) lymphocyte densities (r=-0.74, P=0.046). Conclusion:SBI significantly increases intestinal mucosal CD4(+) lymphocyte counts, improves duodenal function, and showed evidence of promoting intestinal repair in the setting of HIV enteropathy.
引用
收藏
页码:2207 / 2217
页数:11
相关论文
共 64 条
[51]   Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count [J].
Schacker, TW ;
Reilly, C ;
Beilman, GJ ;
Taylor, J ;
Skarda, D ;
Krason, D ;
Larson, M ;
Haase, AT .
AIDS, 2005, 19 (18) :2169-2171
[52]  
Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI 10.1172/JCI0216413
[53]   Optimization of methods to assess human mucosal T-cell responses to HIV infection [J].
Shacklett, BL ;
Yang, O ;
Hausner, MA ;
Elliott, J ;
Hultin, L ;
Price, C ;
Fuerst, M ;
Matud, J ;
Hultin, P ;
Cox, C ;
Ibarrondo, J ;
Wong, JT ;
Nixon, D ;
Anton, PA ;
Jamieson, BD .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 279 (1-2) :17-31
[54]   Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea [J].
Sharpstone, D ;
Neild, P ;
Crane, R ;
Taylor, C ;
Hodgson, C ;
Sherwood, R ;
Gazzard, B ;
Bjarnason, I .
GUT, 1999, 45 (01) :70-76
[55]   Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy [J].
Siddiqui, Uzma ;
Bini, Edmund J. ;
Chandarana, Khushbu ;
Leong, Jennifer ;
Ramsetty, Sabena ;
Schiliro, Danise ;
Poles, Michael .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (05) :484-490
[56]   MCP-1 and CCR2 in HIV infection: Regulation of agonist and receptor expression [J].
Sozzani, S ;
Introna, M ;
Bernasconi, S ;
Polentarutti, N ;
Cinque, P ;
Poli, G ;
Sica, A ;
Mantovani, A .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (01) :30-33
[57]   CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIVmac251 infection [J].
Vaccari, M. ;
Boasso, A. ;
Ma, Z-M ;
Cecchinato, V. ;
Venzon, D. ;
Doster, M. N. ;
Tsai, W. P. ;
Shearer, G. M. ;
Fuchs, D. ;
Felber, B. K. ;
Pavlakis, G. N. ;
Miller, C. J. ;
Franchini, G. .
MUCOSAL IMMUNOLOGY, 2008, 1 (06) :497-507
[58]   HIV swiftly guts the immune system [J].
Veazey, RS ;
Lackner, AA .
NATURE MEDICINE, 2005, 11 (05) :469-470
[59]   Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection [J].
Veazey, RS ;
DeMaria, M ;
Chalifoux, LV ;
Shvetz, DE ;
Pauley, DR ;
Knight, HL ;
Rosenzweig, M ;
Johnson, RP ;
Desrosiers, RC ;
Lackner, AA .
SCIENCE, 1998, 280 (5362) :427-431
[60]   Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection [J].
Wang, Xiaolei ;
Rasmussen, Terri ;
Pahar, Bapi ;
Poonia, Bhawna ;
Alvarez, Xavier ;
Lackner, Andrew A. ;
Veazey, Ronald S. .
BLOOD, 2007, 109 (03) :1174-1181